Fresenius SE & Co KGaA
OTC:FSNUY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fresenius SE & Co KGaA
OTC:FSNUY
|
DE |
|
B
|
British American Tobacco plc
NYSE:BTI
|
UK |
|
Ellington Financial Inc
NYSE:EFC
|
US |
|
G
|
Guangdong Investment Ltd
OTC:GGDVF
|
HK |
|
M
|
MGM Resorts International
BMV:MGM
|
US |
|
L
|
Lundin Gold Inc
F:F1YN
|
CA |
|
Implenia AG
SIX:IMPN
|
CH |
|
COSCO Shipping Holdings Co Ltd
F:C6G0
|
CN |
|
Embla Medical hf
CSE:EMBLA
|
IS |
|
G
|
Genic Co Ltd
KOSDAQ:123330
|
KR |
|
Smith & Nephew PLC
F:NPWA
|
UK |
|
A
|
Agripure Holdings PCL
SET:APURE
|
TH |
Intrinsic Value
Is FSNUY undervalued or overvalued?
See the intrinsic value estimate for 
Fresenius SE & Co KGaA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Fresenius SE & Co KGaA Does
Fresenius SE & Co KGaA is a healthcare company that makes medical products and runs hospitals. Its product side, Fresenius Kabi, sells things like IV fluids, injectable medicines, clinical nutrition products, infusion pumps, and other supplies used in hospitals and clinics. Its hospital side treats patients through large hospital networks in Germany and Spain, where it provides inpatient care, surgeries, and related medical services.
- Headquarters
- Germany DE
- Employees
- 316 078
- IPO date
- Dec 18, 1986
Fresenius SE & Co KGaA has no economic moat
Competing suppliers offer alternatives to many Fresenius medicines and hospital products, while other hospital operators compete for its patients. Its size and reputation help it compete, but do not give it lasting control over customers or prices.
Read the full moat analysis
Revenue & Expenses Breakdown
Fresenius SE & Co KGaA
Earnings Waterfall
Fresenius SE & Co KGaA
The intrinsic value for Fresenius SE & Co KGaA (FSNUY) under the Base Case is hidden USD.
Compared with the current market price of 13.042 USD, the stock appears hidden.